Page last updated: 2024-10-29

iohexol and Patent Foramen Ovale

iohexol has been researched along with Patent Foramen Ovale in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saremi, F1
Channual, S1
Raney, A1
Gurudevan, SV1
Narula, J1
Fowler, S1
Abolhoda, A1
Milliken, JC1
Purvis, JA1
Morgan, DR1
Hughes, SM1

Other Studies

2 other studies available for iohexol and Patent Foramen Ovale

ArticleYear
Imaging of patent foramen ovale with 64-section multidetector CT.
    Radiology, 2008, Volume: 249, Issue:2

    Topics: Contrast Media; Coronary Angiography; Female; Foramen Ovale, Patent; Humans; Iohexol; Linear Models;

2008
Prevalence of patent foramen ovale in a consecutive cohort of 261 patients undergoing routine "coronary" 64-multi-detector cardiac computed tomography.
    The Ulster medical journal, 2011, Volume: 80, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Cardiac-Gated Imaging Techniques; Contrast Media; Coronary Angiograp

2011